ID
44341
Description
NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: End of Treatment. Source: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz
Keywords
Versions (4)
- 12/4/17 12/4/17 -
- 12/7/17 12/7/17 -
- 1/1/18 1/1/18 -
- 9/20/21 9/20/21 -
Copyright Holder
Prof. Dr. med. Georg Heß
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Biopsy GOAL Trial B-cell Lymphoma NCT02499003
Biopsy GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
Similar models
Biopsy GOAL Trial B-cell Lymphoma NCT02499003
- StudyEvent: ODM
C0332448 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
C0332448 (UMLS CUI [1,2])
C0686905 (UMLS CUI [1,2])
C0332448 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
C0332448 (UMLS CUI [1,2])
C0686905 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,2])
C0332448 (UMLS CUI [1,2])
C0686905 (UMLS CUI [1,2])
No comments